Anzeige
Mehr »
Mittwoch, 13.08.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12HJ9 | ISIN: CA8475771033 | Ticker-Symbol: SD4
Frankfurt
12.08.25 | 08:03
0,510 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SPECTRAL MEDICAL INC Chart 1 Jahr
5-Tage-Chart
SPECTRAL MEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,4960,53515:42

Aktuelle News zur SPECTRAL MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15:36XFRA SD4: WIEDERAUFNAHME/RESUMPTION23FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME...
► Artikel lesen
08:29XFRA SD4: AUSSETZUNG/SUSPENSION54DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILSPECTRAL MEDICAL...
► Artikel lesen
01:06Spectral Medical Inc: Spectral's PMX reduces mortality in septic shock trial2
DiSpectral Medical Inc.: Spectral Medical and Vantive Announce Topline Results from Spectral's Tigris Trial Evaluating PMX Hemoadsorption Therapy for Endotoxic Septic Shock26Results exceed prespecified primary endpoint of 95% posterior probability of benefit for PMX on 28-day mortality Pooled absolute risk reduction of 8.3%; Relative risk reduction of 18% Key secondary...
► Artikel lesen
FrSpectral Medical GAAP EPS of $0.00, revenue of $0.81M2
FrSpectral Medical Inc.: Spectral Medical Announces Second Quarter and Provides Corporate Update97Topline Tigris results expected to be released around mid-August 2025 TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic...
► Artikel lesen
SPECTRAL MEDICAL Aktie jetzt für 0€ handeln
04.07.Spectral Medical Inc: Spectral files preliminary prospectus for securities2
04.07.Spectral Medical Inc. Announces Filing of Base Shelf Prospectus3
06.06.Spectral Medical Inc: Spectral Medical shareholders okay all matters at AGM2
06.06.Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders109TORONTO, June 06, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock...
► Artikel lesen
09.05.Spectral Medical reports Q1 results3
09.05.Spectral Medical Inc.: Spectral Medical Announces First Quarter and Provides Corporate Update151Tigris Trial Enrollment completedTopline results expected to be released in August 2025Entered into an up to US$10 million Promissory Note with Vantive to Fund Spectral to PMX commercialization ...
► Artikel lesen
08.05.Spectral Medical is "fundamentally undervalued", Paradigm says2
07.05.Spectral Medical Inc: Spectral Medical to issue $10M (U.S.) note to Vantive2
07.05.Stocks in Play: Spectral Medical Inc.1
07.05.Spectral Medical Inc.: Spectral Medical Announces Non-Dilutive Financing of Up to $10 Million with Vantive212• Non-Dilutive Financing • Up to US$10 Million Promissory Note Provided by Vantive • If Fully Drawn, Promissory Note is Expected to Fully Fund Spectral to PMX Commercialization • Company to...
► Artikel lesen
16.04.Spectral Medical Inc: Spectral Medical completes Tigris patient enrolment2
16.04.Spectral Medical Inc.: Spectral Medical Completes Tigris Trial Enrollment157157 patients enrolledTopline results expected to be released in August 2025Company to host Corporate Update Call on May 15, 2025 TORONTO, April 16, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc....
► Artikel lesen
27.03.Stocks in Play: Spectral Medical Inc.-
27.03.Spectral Medical Inc.: Spectral Medical Announces Fourth Quarter and Fiscal 2024 Results and Provides Corporate Update273TORONTO, March 27, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock...
► Artikel lesen
Weiter >>
23 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1